Therapeutic oligonucleotides act on different stages of pathological gene expression. Standard schematic of oligonucleotide activities in pathogenesis disease progression. Decoys bind to transcription ...

Synthetic Oligonucleotides are set for rapid expansion in healthcare, food production, and data storage. The technology, vital in both existing and new markets, promises vast growth potential often ...

Figure 2: Effect of liposomally encapsulated PB2-as on the virus titer in the lungs of mice infected with 100 LD 50 of influenza A virus. Figure 4: Representative photographs showing the effects of ...

Before being swayed by antibody-drug conjugates, one of GSK’s passion projects was oligonucleotides. As part of this romance, the British Big Pharma signed a research collaboration with Elsie ...

Many cognitive neurodevelopmental disorders are a result of too many or too few copies of certain genes or chromosomes. To date, no treatment options exist for this class of disorders. MECP2 ...

Synthetic oligonucleotides have been used as critical research reagents in the biotechnology industry since its beginning in the 1970s. Their increasing use first led to the formation of many core ...

Scientists have developed a new approach to produce life-saving oligonucleotide therapeutics on a large scale, in high purity, and with minimal environmental impacts. Scientists have developed a new ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. This jar was part of the National ...

Clinics across the U.S. are claiming to treat cancer, Lyme disease, and other bacterial and viral infections with "supportive oligonucleotide therapy (SOT)" -- a treatment lacking both data and FDA ...

- The next frontier in oligonucleotide synthesis is the direct synthesis of gene-length sequences. - Ansa synthesized a 1005 base long oligonucleotide with industry-leading accuracy. - Ansa will be ...

Avidity Biosciences, Inc. (RNA) is an early stage biopharma with a multi-billion dollar valuation. These types of companies always interest me. On the one hand, due to their early stages, they appear ...